scispace - formally typeset
H

Hans-Peter Lenhof

Researcher at Saarland University

Publications -  170
Citations -  6982

Hans-Peter Lenhof is an academic researcher from Saarland University. The author has contributed to research in topics: Cancer & Macromolecular docking. The author has an hindex of 44, co-authored 164 publications receiving 6046 citations. Previous affiliations of Hans-Peter Lenhof include Max Planck Society.

Papers
More filters
Journal ArticleDOI

A new Lamarckian genetic algorithm for flexible ligand‐receptor docking

TL;DR: A Lamarckian genetic algorithm (LGA) variant for flexible ligand‐receptor docking which allows to handle a large number of degrees of freedom and may be used to dock ligands with many rotatable bonds with high efficiency.
Journal ArticleDOI

High-throughput miRNA profiling of human melanoma blood samples

TL;DR: This study provides strong evidence for miRNA expression signatures of blood cells as useful biomarkers for melanoma and finds that blood samples of melanoma patients and healthy individuals can be well differentiated from each other based on mi RNA expression analysis.
Journal ArticleDOI

Multi-omics enrichment analysis using the GeneTrail2 web service

TL;DR: The presented use-case demonstrates that GeneTrail2 is well equipped for the integrative analysis of comprehensive -omics data and may help to shed light on complex pathogenic mechanisms in cancer and other diseases.
Proceedings ArticleDOI

q-gram based database searching using a suffix array (QUASAR)

TL;DR: Multi-purpose, adjustable stabilizing cleats which can be attached to various types of transmission and/or drive shaft tunnel or hump mounted trays with adjustment of the cleats enabling them to be positioned for effective engagement with surface areas of transmission humps or tunnels of different shapes and configurations as discussed by the authors.
Journal ArticleDOI

Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis.

TL;DR: The findings support the idea that a developing lung cancer might be detectable years prior to diagnosis through a specific miRNA signature and that this signature changes during tumor development.